Archives

img-01

Indian Drug Industry Trying to Right the Ship

Earlier this year, the Indian government issued a notification upgrading its drug manufacturing requirements. This notification said that large Indian drug manufacturers had 6 months to upgrade their game, smaller Indian drug makers had 12 months. The notification said Indian drug makers... Read More

img-01

Quick Asian News Brief Updates

Last month the Thai FDA promulgated that the medical device application pre-screening time would be reduced from 30 days to 1 day. In addition, the time to review Class 2-4 device applications would decrease from 200 days to 120 days if an expert... Read More

img-01

India’s Central Drugs Standard Control Organization (CDSCO)

1. Overview The Central Drugs Standard Control Organization (CDSCO) functions as India’s primary regulatory authority overseeing pharmaceuticals, medical devices, and cosmetics. The CDSCO is also responsible for supervising the Drugs Consultative Committee (DCC), the Drugs Technical Advisory Board (DTAB), and the Central... Read More

img-01

India DCGI Extends Device Registration

As noted in our July newsletter, the Indian authorities required all non-notified Class C and D devices to be registered by October 1. Such devices could include certain X-ray products, ventilators, etc. that have moderate to high risks. However, some medical device... Read More